# Evaluating the Effectiveness of Sertraline in Treating Women With Premenstrual Dysphoric Disorder

> **NCT00536198** · PHASE4 · COMPLETED · sponsor: **Yale University** · enrollment: 252 (actual)

## Conditions studied

- Premenstrual Dysphoric Disorder

## Interventions

- **DRUG:** Sertraline
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00536198
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-11-06
- **Primary completion:** 2012-02
- **Final completion:** 2012-02
- **Target enrollment:** 252 (ACTUAL)
- **Last updated:** 2017-04-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00536198

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00536198, "Evaluating the Effectiveness of Sertraline in Treating Women With Premenstrual Dysphoric Disorder". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00536198. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*